What is PU-H71 used for?

PU-H71 is being researched for its potential to treat breast cancer, lymphoma, and myeloproliferative disorders.

Is PU-H71 an approved drug?

No, PU-H71 is currently a research compound in clinical trial phases and is not yet approved for general medical use.

What stage of testing is PU-H71 in?

PU-H71 is currently in Phase 1 and Phase 2 clinical testing stages.

Can PU-H71 treat lymphoma?

Studies are looking into whether PU-H71 can be used to treat lymphoma.

Can PU-H71 treat breast cancer?

Research indicates that PU-H71 is being investigated for its effects on breast cancer.

What kind of molecule is PU-H71?

PU-H71 is categorized as a small molecule.

Zelavespib | CAS 873436-91-0 | SUPVGFZUWFMATN

Loading compound...

Small molecule research compound

PU-H71 is a small molecule research compound currently being studied for its potential to treat certain types of cancer, such as breast cancer and lymphoma, as well as myeloproliferative disorders.

How it worksPU-H71 is a small molecule that has been studied for its ability to interact with various biological targets related to cancer cell growth.

Used for

Breast cancerLymphomaMyeloproliferative disorders

Conditions

Breast cancerLymphomaMyeloproliferative disorders

Class

Small moleculeSmall molecule research compound

How to take

This compound is currently in clinical research phases (Phase 1 and Phase 2) and is not an FDA-approved medication for general use.

Talk to your doctor

Questions to ask

·Is PU-H71 part of any clinical trials I might qualify for?
·What are the current research findings for PU-H71 in lymphoma?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)